Olowu WA. Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome. World J Nephrol. Feb 6 2012;1(1):16-24.

Parekh RS, Carroll CE, Wolfe RA, Port FK. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr. Aug 2002;141(2):191-197.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. Sep 23 2004;351(13):1296-1305.

Maurer M, Burri S, de Marchi S, et al. Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome. Int J Cardiol. May 14 2010;141(1):32-38.

Rigatto C, Parfrey PS. Homocysteine and cardiovascular risk in dialysis patients. Perit Dial Int. Mar-Apr 2000;20(2):167-168.

Heinz J, Kropf S, Luley C, Dierkes J. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am J Kidney Dis. Sep 2009;54(3):478-489.

Bekpinar S, Unlucerci Y, Genc S, Turkmen A. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients. Adv Perit Dial. 2005;21:80-84.

Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. Mar 2008;3(2):505-521.

Silva de Almeida CC, Guerra DC, Vannucchi MT, Geleilete TJ, Vannucchi H, Chiarello PG. What is the meaning of homocysteine in patients on dialysis? J Ren Nutr. Sep 2011;21(5):394-400.

Zoccali C, Mallamaci F, Tripepi G. It is important to lower homocysteine in dialysis patients. Semin Dial. Nov-Dec 2007;20(6):530-533.

Strain JJ, Dowey L, Ward M, Pentieva K, McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc. Nov 2004;63(4):597-603.

Tayebi-Khosroshahi H, Dehgan R, Habibi Asl B, et al. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients. Iran J Kidney Dis. Nov 2013;7(6):479-484.

Savaj S. Omega-3 and serum homocysteine level in hemodialysis patients. Iran J Kidney Dis. Nov 2013;7(6):421-422.

Tamadon MR, Jamshidi L, Soliemani A, Ghorbani R, Malek F, Malek M. Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis. Iran J Kidney Dis. Mar 2011;5(2):93-96.

Soleimani A, Usefzadeh M, Mianehsaz E, et al. Comparison of oral folic acid and folinic acid on blood homocysteine level of patients on hemodialysis. Iran J Kidney Dis. Jan 2011;5(1):45-49.

Sombolos K, Papaioannou A, Christidou F, et al. The effect of two different doses comprising the simultaneous administration of intravenous B-complex vitamins and oral folic acid on serum homocysteine levels in hemodialysis patients. Int Urol Nephrol. 2006;38(3-4):725-730.

Obeid R, Kuhlmann MK, Kohler H, Herrmann W. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients. Clin Chem. Jan 2005;51(1):196-201.

Naseri M, Mottaghi Moghadam Shahri, Horri M, et al. Mild Hyperhomocysteinemia in Children and Young Adults on Dialysis. J Ped. Nephrology 2015;3[4]